logo-loader

Full interview: Lexagene takes part in beta testing it’s technology in cannabis industry

Published: 12:39 05 Sep 2019 EDT

Lexagene (LXG) CEO and Co-Founder Dr Jack Regan joined Steve Darling from Proactive Vancouver on Skye to discuss the beta testing Lexagene did with CDX Analytics for rapid pathogen detection in cannabis and hemp.

Regan telling Proactive what the testing was looking for and the results as well. He also shared the next steps in the process.

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

3 hours, 37 minutes ago